| ||
| Nine Things I Learned From the 'Cell Phone-Cancer' News DNAinfo It doesn't mean that, you know, we're going to be walking down the streets and people are going to be falling over dying of brain cancer. You know, the overall number of people that develop brain cancer, you know, it is not like lung cancer or breast ... See all stories on this topic » | ||
| ZIOPHARM Oncology Announces Acceptance of Investigational New Drug Application ... TradersHuddle.com (press release) The Company is also currently conducting a Phase I intravenous study of palifosfamide in combination with standard of care addressing small cell lung cancer and an oral form of the drug for treatment of solid tumors is currently in the advanced ... See all stories on this topic » |
| ||
| Bevacizumab therapy in advanced non-small cell lung cancer (NSCLC ... Bevacizumab therapy in advanced non-small cell lung cancer (NSCLC): Outcomes from a community oncology network. - ASCO - The American Society of Clinical ... www.asco.org/ASCOv2/Meetings/Abstracts?&...abst... | ||
| Pulmonary resection for lung cancer with malignant pleural disease ... Objectives: The prognosis of non-small-cell lung cancer (NSCLC) patients with malignant pleural disease (MPD), characterized by malignant pleural effusion ... www.sciencedirect.com/science/article/.../S101079401100458... | ||
| OXiGENE releases promising phase two data for lung cancer drug OXiGENE updates data on FALCON trial for non-small cell lung cancer. OXiGENE, Inc., a clinical-stage, biopharmaceutical company developing novel ... www.bioportfolio.com/.../Oxigene-Releases-Promising-Phase-... |
This once a day Google Alert is brought to you by Google.
Remove this alert.
Create another alert.
Manage your alerts.
No comments:
Post a Comment